Cell Density Speaks Volumes About Cancer Treatment Choices
FDA Approves Immune Checkpoint Inhibitor Drug for Patients With Resectable Locally Advanced Head and Neck Cancer
Double Negative in Cells Could Undermine PARP Inhibitors
The Angeles Clinic and Research Institute
T-DXd Plus Pertuzumab Outperforms Standard of Care for First-Line Treatment of Advanced HER2-Positive Breast Cancer
Diet Influences Survival After Stage III Colon Cancer, Dana-Farber Study Finds
Adding Immune Checkpoint Inhibitor to Standard Chemotherapy Regimen Improves Outcomes in Stage 3 Colon Cancer, Study Finds
ADC Combination Outperforms Standard Treatment of Advanced Triple-Negative Breast Cancer
EQUAL Study Launches Lung Cancer Screening Trial for People at High Risk
New Study Unveils Potential Therapeutic Pathways for Aggressive Pediatric Brain Tumor
Clinical Trial Offers CAR T-Cell Therapy Targeting MUC16 for Recurrent/Refractory Ovarian Cancer
Molecular Tripwires and Sponges Evolved in Bacterial Struggle for Survival
What is Immunopeptidomics?
New Insights into Immunotherapy Targets for Pancreatic Cancer
Chain Reaction: The Belzutifan Journey
Showing 46 - 60 of 1049 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...70 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
